Cas:2092925-71-6 2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel- manufacturer & supplier

We serve Chemical Name:2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel- CAS:2092925-71-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel-

Chemical Name:2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel-
CAS.NO:2092925-71-6
Synonyms:2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel-
Molecular Formula:N/A
Molecular Weight:N/A
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:
Exact Mass:
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel- Use and application,2H-Pyran, 2-(4-bromophenyl)-5-ethyltetrahydro-, (2R,5S)-rel- technical grade,usp/ep/jp grade.


Related News: Over the past two to three years, VBP has become “quite a challenge,” AZ’s international and China market chief Leon Wang said on the call. In response, the company has resorted to multichannel marketing, turning to the retail pharmacy market to soften the blow of tender losses. oxolan-2-ylmethyl 2-hydroxybenzoate manufacturers As for the expansion itself, Takeda will build a new 15,000-square-foot manufacturing facility at the site and expand an existing 14,000-square-feet of production space. Takeda has been knocking around the Thousand Oaks area since 1996, the Business Times said. Polyglutamic Acid suppliers The company will see an immediate $6 billion bump to its topline thanks to Alexion’s C5 inhibitors, used to treat rare diseases like paroxysmal nocturnal hemoglobinuria. Methyl 5-bromo-2-methoxybenzoate vendor & factory.